ZNF502
Zinc finger protein 502
Also known as: FLJ12515, FLJ14855, ZN502_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TBZ5
- Gene
- ZNF502
- Ensembl
- ENSG00000196653
- Chromosome
- 3
- Canonical length
- 544 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in positive regulation by host of viral process and viral release from host cell. Located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
544 residues, UniProt reviewed canonical sequence.
>Q8TBZ5|ZNF502
1 MLNMQGAEER DIRRETCPGW VNKNKPALEQ DVCKIDSSGI VVKRFQEDEY QDSTFEEKYA
61 CEGMKENSPR EIAESCLFQE GGFGRITFIH KEAPPEIISQ GYNFEKSLLL TSSLVTRLRV
121 STEESLHQWE TSNIQTNDIS DQSKCPTLCT QKKSWKCNEC GKTFTQSSSL TQHQRTHTGE
181 RPYTCEECGK AFSRSSFLVQ HQRIHTGVKP YGCEQCGKTF RCRSFLTQHQ RIHTGEKPYK
241 CNECGNSFRN HSHLTEHQRI HTGEKPYKCN RCGKAFNQNT HLIHHQRIHT GEKPYICSEC
301 GSSFRKHSNL TQHQRIHTGE KPHKCDECGK TFQTKANLSQ HQRIHSGEKP YKCKECGKAF
361 CQSPSLIKHQ RIHTGEKPYK CKECGKAFTQ STPLTKHQRI HTGERPYKCS ECGKAFIQSI
421 CLIRHQRSHT GEKPYKCNEC GKGFNQNTCL TQHMRIHTGE KPYKCKECGK AFAHSSSLTE
481 HHRTHTGEKL YKCSECEKTF RKYAHLSEHY RIHTGEKPYE CIECGKFFRH SSVLFRHQKL
541 HSGDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF502 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 5.3 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 5.3 nTPM
- ovary: 5 nTPM
- retina: 4.8 nTPM
- testis: 4.8 nTPM
- prostate: 4.6 nTPM
- cervix: 4.4 nTPM
Single-cell type
- bergmann glia: 7.9 nCPM
- renal connecting tubule cells: 7.8 nCPM
- brain inhibitory neurons: 7.5 nCPM
- brain excitatory neurons: 6.9 nCPM
- oligodendrocyte progenitor cells: 6.8 nCPM
- papillary tip epithelial cells: 6.6 nCPM
Immune cell
- naive CD4 T-cell: 1.5 nTPM
- naive B-cell: 1.2 nTPM
- naive CD8 T-cell: 1.2 nTPM
- NK-cell: 1.2 nTPM
- MAIT T-cell: 1 nTPM
- memory CD4 T-cell: 1 nTPM
Brain region
- cerebellum: 4.5 nTPM
- hypothalamus: 2.7 nTPM
- basal ganglia: 2.6 nTPM
- midbrain: 2.5 nTPM
- cerebral cortex: 2.4 nTPM
- medulla oblongata: 2.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.62
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- host-mediated activation of viral process
- regulation of DNA-templated transcription
- viral release from host cell
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF502 as an antibody target. Whether an autoantibody or antibody against ZNF502 could matter depends on whether native ZNF502 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF502 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF502 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...